These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27606932)

  • 1. Who Benefits From a Tumor Bed Boost After Whole-Breast Radiotherapy?
    Cuttino LW; Kubicky CD
    JAMA Oncol; 2017 Jan; 3(1):21-22. PubMed ID: 27606932
    [No Abstract]   [Full Text] [Related]  

  • 2. Boost or not.
    Morgan DA; Robertson JF
    J Clin Oncol; 2008 Feb; 26(6):1013-4; author reply 1014. PubMed ID: 18281678
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach.
    Wenz F; Welzel G; Blank E; Hermann B; Steil V; Sütterlin M; Kraus-Tiefenbacher U
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1309-14. PubMed ID: 20100643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy breast boost with reduced whole-breast dose is associated with improved cosmesis: the results of a comprehensive assessment from the St. George and Wollongong randomized breast boost trial.
    Hau E; Browne LH; Khanna S; Cail S; Cert G; Chin Y; Clark C; Inder S; Szwajcer A; Graham PH
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):682-9. PubMed ID: 21255943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
    Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
    Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Planning the breast tumor bed boost: changes in the excision cavity volume and surgical scar location after breast-conserving surgery and whole-breast irradiation.
    Oh KS; Kong FM; Griffith KA; Yanke B; Pierce LJ
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):680-6. PubMed ID: 16863683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative radiotherapy (IORT) with 50-kv X-ray machines as boost in breast cancer -- more questions than answers.
    Strnad V
    Onkologie; 2006 Mar; 29(3):73-5. PubMed ID: 16514266
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor bed boost omission after negative re-excision in breast-conservation treatment.
    Arthur DW; Cuttino LW; Neuschatz AC; Koo DT; Morris MM; Bear HD; Kaplan BJ; Dawson K; Wazer DE
    Ann Surg Oncol; 2006 Jun; 13(6):794-801. PubMed ID: 16614879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
    Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
    Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
    Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More questions about the European Organisation for Research and Treatment of Cancer 22881-10882 boost trial.
    Guinot JL
    J Clin Oncol; 2011 Mar; 29(8):e212; author reply e213. PubMed ID: 21263085
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast Radiation Therapy--Sometimes Less May Be More.
    Jagsi R; Woodward WA
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):1-3. PubMed ID: 26279015
    [No Abstract]   [Full Text] [Related]  

  • 13. Single-center long-term follow-up after intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage x-rays.
    Blank E; Kraus-Tiefenbacher U; Welzel G; Keller A; Bohrer M; Sütterlin M; Wenz F
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():352-8. PubMed ID: 20853058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Planning the breast boost: comparison of three techniques and evolution of tumor bed during treatment.
    Hepel JT; Evans SB; Hiatt JR; Price LL; DiPetrillo T; Wazer DE; MacAusland SG
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):458-63. PubMed ID: 19084347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in post-surgical lumpectomy cavity volume with delay in initiation of breast irradiation because of chemotherapy.
    Strauss JB; Gielda BT; Chen SS; Shah AP; Abrams RA; Griem KL
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):831-5. PubMed ID: 19800179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer radiotherapy: controversies and prospectives.
    Yu JM; Wang YS
    Chin Med J (Engl); 2008 Oct; 121(20):1957-9. PubMed ID: 19080255
    [No Abstract]   [Full Text] [Related]  

  • 17. Controversies in loco-regional treatment: post-mastectomy radiation for pT2-pT3N0 breast cancer arguments in favour.
    Valli MC;
    Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e70-4. PubMed ID: 21134765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer.
    Kim JY; Jung SY; Lee S; Kang HS; Lee ES; Park IH; Lee KS; Ro J; Lee NK; Shin KH
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1037-42. PubMed ID: 24267970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
    Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
    Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
    Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
    Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.